NASDAQ:NDAQ

Nasdaq Stock News

Financial Services > Financial - Data & Stock Exchanges

Buy NDAQ

*Your capital is at risk

$77.65

-3.96 (-4.85%)

At Close: Jun 25, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

04:01pm, Friday, 02'nd Aug 2024

SAN DIEGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent s

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04:00pm, Friday, 02'nd Aug 2024

WESTLAKE VILLAGE, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in

Q3's Rising Stars: 3 Nasdaq Stocks for Your Must-Watch List

03:33pm, Friday, 02'nd Aug 2024

The growth and tech-heavy Nasdaq 100 index is in something of a significant correction at the moment. After hitting new all-time highs early in July, the benchmark Invesco QQQ ETF (NASDAQ: QQQ ) has a

The 3 Best Stocks to Buy Doing Successful Secondary Offerings in 2024

03:31pm, Friday, 02'nd Aug 2024

The IPO (initial public offering) market has gotten stronger in 2024, according to the Q2 2024 quarterly review from IPO specialist Renaissance Capital. That has resulted in a more buoyant market for

Nasdaq Tumbles Over 3% After Jobs Report Sparks Recession Fears

10:58am, Friday, 02'nd Aug 2024

Stocks across several industries fell Friday, after the Labor Department reported the U.S. economy added fewer jobs than expected last month, stoking fears of a possible recession.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

08:00am, Friday, 02'nd Aug 2024

DALLAS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07:00am, Friday, 02'nd Aug 2024

RESEARCH TRIANGLE PARK, N.C., Aug. 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted n

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06:30am, Friday, 02'nd Aug 2024

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted eleven n

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06:50pm, Thursday, 01'st Aug 2024

RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced the grant of inducement stock options exerci

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06:00pm, Thursday, 01'st Aug 2024

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small mole

Nasdaq 100 Heavyweights Report: Apple Shines, Intel Stumbles, Snap and Amazon Miss Targets

05:08pm, Thursday, 01'st Aug 2024

Tech giants report mixed Q2. Apple shines, Snap and Amazon miss targets, Intel restructures.

Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

04:36pm, Thursday, 01'st Aug 2024

PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by